The Receptor for Type I IFNs Is Highly Expressed on Peripheral Blood B Cells and Monocytes and Mediates a Distinct Profile of Differentiation and Activation of These Cells-Reference-Cited by-同舟云学术

The Receptor for Type I IFNs Is Highly Expressed on Peripheral Blood B Cells and Monocytes and Mediates a Distinct Profile of Differentiation and Activation of These Cells

Published:2004-02 Issue:2 Volume:24 Page:131-139
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Pogue Sarah L.¹,Preston Benjamin T.,Stalder Joseph,Bebbington Christopher R.,Cardarelli Pina M.

Affiliation:

1. Department of Cell Biology, Corixa Corporation, South San Francisco, CA 94080; Medarex, Inc., Milpitas, CA 95035.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/107999004322813372

Reference30 articles.

1. Structure of the Human Type-I Interferon Gene Cluster Determined from a YAC Clone Contig

2. INTERFERONS AND THEIR ACTIONS

3. The Type I Interferon Receptor: Structure, Function, and Evolution of a Family Business

4. Differential Responsiveness of a Splice Variant of the Human Type I Interferon Receptor to Interferons

5. Shared receptor components but distinct complexes for α and β interferons 1 1Edited by M. Yaniv

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis;International Journal of Molecular Sciences;2024-07-20

2. Helminth induced monocytosis conveys protection from respiratory syncytial virus infection in mice;Allergy;2024-06-26

3. Cytokines and microRNAs in SARS-CoV-2: What do we know?;Molecular Therapy - Nucleic Acids;2022-09

4. RUNX1 Regulates a Transcription Program That Affects the Dynamics of Cell Cycle Entry of Naive Resting B Cells;The Journal of Immunology;2021-11-22

5. S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases;Journal of Translational Autoimmunity;2021